Predictive Health Diagnostics Company Announces Partnership with Madison Core Laboratories for PULS Cardiac Test™ Distribution to 30+ Healthcare Facilities
Distribution targeted to high at-risk co-morbid patient populations
Predictive Health Diagnostics Company Announces Expansion of North American Sales Force
Predictive Health Diagnostics Company expanding sales team to drive market expansion
PULS Cardiac Test™ and DIABETESpredict™ diagnostic tests now being marketed to healthcare providers throughout North America
Predictive Health Diagnostics Company Launches Second Diagnostic Test DIABETESpredict™ in North America
Enters into exclusive distribution agreement with Patia Europe SL, developer of DIABETESpredict.
Predictive Health Diagnostics Company Announces Strong Momentum with 120,000th PULS Cardiac Test™ Order
One-of-a-kind diagnostic blood test identifies asymptomatic at-risk patients missed by the current standard of care.
Predictive Health Diagnostics Company’s Proprietary Computational Technology Enables Development of Specialty Diagnostic Tests to Improve Patient Care
Company announces its business strategy including test development, commercialization, intellectual property, and reimbursement initiatives.